REGIONE EMILIA ROMAGNA Linee guida per la diagnosi ... - Saluter

More documents

Recommendations

Info

______________________________________________________________________________________ _ 40
6 LINEE GUIDA O DOCUMENTI DI CONSENSO ESISTENTI ESAMINATI • Assessement: neurosychological testing for adults. Consideration for neurologists. Report of the Therapeutics and Technology Assessement Subcommittee of the American Academy of Neurology. Neurology 47:592-599 (1996) • Bonavita V, Caltagirone C et al per la Società Italiana di Neuroscienze; Expert Panel Alzheimer. Malattia di Alzheimer. Documento di Consenso. Il Pensiero Scientifico Editore, Roma, 1999 • Brodaty H, Dresser R, Eisner M, Erkunjuntti T, Gauthier S, Graham N, Jonker C, Sachs G, Whitehouse P Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia. Alzheimer Dis Assoc Disord 1999 Apr-Jun;13(2):71-9 • Costa, P. T.;Williams, T. F.;Albert, M. S.;Butters, N. M.;Folstein, M. F.;Gilman, S.;Gurland, B. J.;Gwyther, L. P.;Heyman, A.;Kaszniak, A. W. Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias. Clinical Practice Guideline Number 19; Early Identification of Alzheimer's Disease and Related Dementias. Quick Reference Guide for Clinicians Number 19; Early Alzheimer's Disease, Consumer Version. Patient and Family Guide. AHCPR, National Center for Health Services Research, Technical Report n 97-0703, 1996 • Eccles M, Clarke J, Livingstone M,Freemantle N, Mason J. North of England evidence based guidelines development project: guideline for the primary care management of dementia. BMJ 1998;317:802-808 • Fillit H, Cummings J Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Manag Care Interface 2000 Jan;13(1):51-6 • Lovestone S, Graham N, Howard R. Guidelines on drug treatments for Alzheimer's disease. Lancet 350:232-233, 1997 • National Institute on Aging/Alzheimer’s Association Working Group. Apolipoprotein E genotyping in Alzheimer’s disease. Lancet 347:1091-1095 (1996) • NIH Consensus Conference: Differential diagnosis of dementing diseases. JAMA; 23:3411-3416; 1987. • Post SG, Whitehouse PJ Fairhill guidelines on ethics of the care of people with Alzheimer's disease: a clinical summary. Center for Biomedical Ethics, Case Western Reserve University and the Alzheimer's Association. Alzheimer Dis Assoc Disord 1994;8 Suppl 4:66-74 • Rabins P, Blacker D, Bland W, Bright-Long L, Cohen E, Katz I et al. Practice guideline for treatment of patients with Alzheimer’s disease and other dementias of late life. Am J Psychiatry 1997;154:5 (s):1-39 • Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus Statement of the American Association for Geriatric psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA 1997, 278:1363-1371 ______________________________________________________________________________________ _ 7 CRITERI DIAGNOSTICI 41
Page 1: REGIONE EMILIA ROMAGNA Linee guida
Page 4 and 5: 1 INTRODUZIONE 1.1 Significato e li
Page 6 and 7: 2 DEMENZA E INVECCHIAMENTO Per molt
Page 8 and 9: Recentemente sono state fornite ult
Page 10 and 11: anatomo-patologio e clinico. L’AD
Page 12 and 13: ecc.); generalmente è in grado di
Page 14 and 15: inattenzione, disturbo di memoria,
Page 16 and 17: sintomi psicotici. I disturbi dell'
Page 18 and 19: anche essere alla base della compar
Page 20 and 21: ___________________________________
Page 22 and 23: stato confusionale non si risolve o
Page 24 and 25: 1 Figura 1 S 7 Algoritmo per la val
Page 26 and 27: carico assistenziale dei caregiver.
Page 28 and 29: pertanto ricercate con attenzione.
Page 30 and 31: ase delle informazioni ottenute dal
Page 32 and 33: 4.7 Le indagini strumentali Gli esa
Page 34 and 35: particolare) sembra essere uno stru
Page 36 and 37: Nelle fasi avanzate della demenza i
Page 38 and 39: In passato si era ritenuto che la d
Page 42 and 43: • American Psychiatric Associatio
Page 44 and 45: • Frisoni GB, Beltramello A, Bian
Page 46 and 47: 9.3 Tabella 3 I criteri per la diag
Page 48 and 49: 9.2 Tabella 2 I criteri diagnostici
Page 50 and 51: 9.4 Tabella 4 Prevalenza della deme
Page 52 and 53: 9.6 Tabella 6 Frequenza delle varie
Page 54 and 55: 9.8 Tabella 8 Raccomandazioni per l
Page 56 and 57: 1. Può essere formulata sulla base
Page 58 and 59: o della ACA), o lacune multiple nei
Page 60 and 61: 9.12 Tabella 12 Criteri per la diag
Page 62 and 63: 9.13 Tabella 13 Criteri clinci per
Page 64 and 65: 9.15 Tabella 15 Caratteristiche cli
Page 66 and 67: 9.17 Tabella 17 Il percorso per la
Page 68 and 69: Sintomi cognitivi Deficit mnesici D
Page 70 and 71: 9.21 Tabella 20 Coefficienti di agg
Page 72 and 73: 9.23 Tabella 22 Il follow-up del pa
Page 74 and 75: 9.25 Tabella 24 MONITORAGGIO DEI PI
Page 76 and 77: 9.27 Tabella 25 VALUTAZIONE NEUROPS

REGIONE EMILIA ROMAGNA Linee guida per la diagnosi ... - Saluter

Create successful ePaper yourself

Delete template?

Save as template?